DGX is poised for solid Q3 2025 results, backed by strong DIS growth, strategic M&A and robust test demand across key health segments.

A cancer treatment laboratory in Lewisville recently made a medical breakthrough that could greatly decrease the risk of the ...

Quest Diagnostics Inc raised its full-year earnings expectations on Thursday after a strong quarterly beat and forecast robust demand for COVID-19 tests during the fall season and into 2021.

Guardant Health faces high valuation, reimbursement, and scaling risks, warranting caution for investors. Learn why GH stock ...

The Global Cholesterol Testing Products and Services Market, valued at USD 19.70 billion in 2024, is poised for substantial growth, projected to reach new heights by 2033 with a strong compound annual ...

Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of ...

A QHIN and interoperability pro explains what clean, standardized and interoperable data enables with AI. He also details ...

The race is on to harness the near-infinite power of nuclear fusion—by building a star on Earth. And scientists are closer ...

The global sales of Zika virus testing is estimated to be worth USD 244.7 million in 2025 and anticipated to reach a value of ...

Trump is heading to the Middle East this weekend for the formal signing of the ceasefire deal he helped broker between Israel ...

Time and time again, history presents its lessons - but the power-intoxicated never learn.There comes a time in the life of every nation when the weight of ...

Finnish health tech company Oura has secured over $900 million in fresh funding, led by Fidelity Management & Research ...